Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for Resistant Non-infectious Corneal Ulcer
NCT05924893Completed
- Sponsor
- Minia University
- Start
- Jan 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of naltrexone in corneal ulcer (2 arms), sponsored by Minia University. Primary endpoint: healing of ulcer at 2 weeks. Started Jan 2021; status: completed.
02
Drugs
naltrexone
03
Conditions
corneal ulcer
Beyond the preview
Go deeper on NCT05924893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05924893.